Characteristics | E. faecalis | E. faecium | Total |
Total n. (%) | 12 (34.3) | 23 (65.7) | 35 (100.0) |
Source n. (%) |
|
|
|
ICU | 5 (14.3) | 6 (17.1) | 11 (31.4) |
COU | 3 (8.6) | 11 (31.4) | 14 (40.0) |
Medical Clinic | 3 (8.6) | 2 (5.7) | 5 (14.3) |
Emergency | 0 (0.0) | 1 (2.9) | 1 (2.9) |
Cardiology | 1 (2.9) | 3 (8.6) | 4 (11.4) |
Origin n. (%) |
|
|
|
Rectal swab | 7 (20.0) | 18 (51.4) | 25 (71.4) |
Blood | 4 (11.4) | 1 (2.9) | 5 (14.3) |
Urine | 0 (0.0) | 4 (11.4) | 4 (11.4) |
Catheter | 1 (2.9) | 0 (0.0) | 1 (2.9) |
Resistance profile |
|
|
|
AMP | 1 (2.9) | 21 (60.0) | 22 (62.9) |
PEN G | 5 (14.3) | 22 (62.8) | 27 (77.1) |
VAN | 12 (34.3) | 23 (65.7) | 35 (100.0) |
DAP | 4 (11.4) | 8 (22.9) | 12 (34.3) |
LIN | 1(2.9) | 4 (11.4) | 5 (14.3) |
Biofilm formation n. (%) |
|
|
|
Strong biofilm on hydrophobic substrate | 10 (28.6) | 7 (20.0) | 17 (48.6) |
Strong biofilm on hydrophilic substrate | 2 (5.7) | 0 (0.0) | 2 (5.7) |
Strong TSB biofilm | 9 (25.7) | 4 (11.4) | 13 (37.1) |
Strong BHI biofilm | 5 (14.3) | 4 (11.4) | 9 (25.7) |
Cellular hydrophobicity n. (%) |
|
|
|
HFL | 2 (5.7) | 22 (62.9) | 24 (68.6) |
M HFB | 9 (25.7) | 1 (2.9) | 10 (28.6) |
HFB | 1 (2.9) | 0 (0.0) | 1 (2.9) |
Virulence genes n. (%) |
|
|
|
gelE | 2 (5.7) | 17 (48.6) | 19 (54.3) |
esp | 2 (5.7) | 17 (48.6) | 19 (54.3) |
asa1 | 7 (20.0) | 1 (2.9) | 8 (22.9) |